James J. Burke
- Obstetrics and Gynecology top 0.5%
- Endometrial and Cervical Cancer Treatments 8
- Uterine Myomas and Treatments 4
- Reproductive Medicine top 1%
- Ovarian cancer diagnosis and treatment 13
- Endometriosis Research and Treatment 3
- Epidemiology top 10%
- Oncology top 10%
-
- Sarcoma Diagnosis and Treatment 4
-
- Estrogen and related hormone effects 3
-
- Colorectal and Anal Carcinomas 3
-
- Reproductive Biology and Fertility 2
- Co-authors
- Cornelia L. TrimbleRichard J. ZainoJames KaudererSteven M. SilverbergPeter LimDavid S. AlbertsJohn P. CurtinNick M. Spirtos
- Partner nations
- United StatesSouth KoreaUnited Kingdom
In The Last Decade
James J. Burke
27 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Obstetrics and Gynecology 984
- Reproductive Medicine 674
- Epidemiology 321
- Oncology 242
- Cancer Research 133
Countries citing papers authored by James J. Burke
This map shows the geographic impact of James J. Burke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James J. Burke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James J. Burke more than expected).
Fields of papers citing papers by James J. Burke
This network shows the impact of papers produced by James J. Burke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James J. Burke. The network helps show where James J. Burke may publish in the future.
Co-authorship network
The 25 scholars most cited alongside James J. Burke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 118 | |
| 2 | Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early-Stage Endometrial Cancerbreakdown → | 2019 | 209 |
| 3 | 2016 | 17 | |
| 4 | 2014 | 93 | |
| 5 | 2012 | 54 | |
| 6 | 2011 | 44 | |
| 7 | 2011 | 12 | |
| 8 | 2011 | 67 | |
| 9 | 2011 | 16 | |
| 10 | 2010 | 47 | |
| 11 | 2006 | 23 | |
| 12 | 2006 | 401 | |
| 13 | 2006 | 36 | |
| 14 | Metastatic uterine serous carcinoma originating in an endometrial polyp: a report of 2 cases. | 2005 | 2 |
| 15 | 2005 | 4 | |
| 16 | 2004 | 12 | |
| 17 | 2004 | 20 | |
| 18 | 1997 | 12 | |
| 19 | 1990 | 67 | |
| 20 | 1988 | 49 |
About James J. Burke
James J. Burke is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Otorhinolaryngology, having authored 27 papers that have together received 1.6k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (13 papers), Endometrial and Cervical Cancer Treatments (8 papers), Sarcoma Diagnosis and Treatment (4 papers), Uterine Myomas and Treatments (4 papers), Estrogen and related hormone effects (3 papers), Colorectal and Anal Carcinomas (3 papers), Endometriosis Research and Treatment (3 papers) and Reproductive Biology and Fertility (2 papers). The work is most often cited by research in Obstetrics and Gynecology (984 citations), Reproductive Medicine (674 citations) and Epidemiology (321 citations). James J. Burke has collaborated with scholars based in United States, South Korea and United Kingdom. Frequent co-authors include Cornelia L. Trimble, Richard J. Zaino, James Kauderer, Steven M. Silverberg, Peter Lim, David S. Alberts, John P. Curtin, Nick M. Spirtos, Virginia L. Filiaci and Donald G. Gallup. Their work appears in journals such as JAMA, Journal of Clinical Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.